Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Private Placement: Ready for a Golden Opportunity in Ghana and Canada? (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
SCYNEXIS Inc
SCYX
Healthcare
SCYNEXIS, Inc. is a biotechnology company. The Company is developing its lead product candidate, ibrexafungerp, as a broad-spectrum, intravenous (IV)/oral agent for multiple fungal indications in both the community and hospital settings. Its Ibrexafungerp has demonstrated activity against a large collection of medically relevant strains of Candida and Aspergillus genera, including multidrug...
-resistant strains, as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera. The Company has received approval from the United States Food and Drug Administration (FDA) for the New Drug Application (NDA) for BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC, also known as vaginal yeast infection), and for the reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC), respectively.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SCYX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(107)
•••
JonathanJSmith
X
Comment by
JonathanJSmith
on Mar 31, 2023 9:34am
RE:RE:wtf?
They sold the drug, not the company. Too bad, I wish they had sold the entire company. I guess this useless management team gets to keep its jobs for the time being. If someone was lucky to get
...more
(81)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 30, 2023 11:52am
RE:wtf?
Great timing Mr. Smith...... Care to stick your other foot in your mouth?? Don't quit ur day job !
Datametrex AI Launches AnalyticsGPT
posted Sep 24, 2023 9:00am by
Datametrex AI Ltd
-
|
The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. In the following weeks, Datametrex will be announcing additional packages and pricing models designed to allow smaller businesses to leverage the power of ...read more
(107)
•••
JonathanJSmith
X
Post by
JonathanJSmith
on Mar 16, 2023 11:49am
wtf?
What happened to these guys? What a disgrace. Fire the entire management team and start anew. Sell this company for what can be salvaged. I can't believe how wrong I was with this one. Oh
...more
(107)
•••
JonathanJSmith
X
Post by
JonathanJSmith
on Aug 02, 2022 8:23am
Can we expect additional Rx's to the fold this winter?
It's been a while and I've had some time to digest several variables; here are some of my findings: These guys are still trading well below cash, which is interesting. According to their most
...more
(107)
•••
JonathanJSmith
X
Comment by
JonathanJSmith
on Apr 26, 2022 8:33am
RE:RE:RE:RE:BREXAFEMME - published User side effects
I'm disgusted too. What does $45MM get them, another quarter's worth of financing - maybe two? One would think that they'd do a financing AFTER their sNDA submittal. I guess they
...more
(31)
•••
dmacd
X
Comment by
dmacd
on Apr 22, 2022 4:48pm
RE:RE:RE:BREXAFEMME - published User side effects
I was going to sell at a loss, but decided to lower my average cost due to the discount. They will have $150M cash less Q1 spend. Probably trading at 70% current cash with an approved blockbuster drug
...more
(107)
•••
JonathanJSmith
X
Comment by
JonathanJSmith
on Mar 31, 2022 12:33pm
RE:RE:BREXAFEMME - published User side effects
Yeah, I agree - worse sales than I had expected. They should get a pop however when they submit their supplemental NDA vis-a-vis rVVC in Q2. I'm still holding as their MC is hovering around cash
...more
(31)
•••
dmacd
X
Comment by
dmacd
on Mar 29, 2022 11:39am
RE:BREXAFEMME - published User side effects
The problem is Mario and Christine are spending with reckless abandon. We need a businessman to run the company not a doctor. Mario can raise money but it dilutes so value is not delivered. Burry will
...more
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(0)
•••
GMA133
X
Post by
GMA133
on Feb 07, 2022 3:22pm
BREXAFEMME - published User side effects
Join me by taking your action by contacting SCYX Investor Relations. Today, I emailed Irina of SCYX - Investor Relations & recommended that Marco Taglietti, M.D. launch a
...more
(31)
•••
dmacd
X
Comment by
dmacd
on Jan 21, 2022 3:35pm
RE:RE:RE:RE:RE:Stop Raising Dilutive Funds
Valued at cash again... well plus the long term debt. Expecting $20M burn as sales will take a while. Question is can they avoid another dilution with profits within next 3 or 4 quarters. The new
...more
(107)
•••
JonathanJSmith
X
Comment by
JonathanJSmith
on Dec 06, 2021 3:16pm
RE:RE:RE:RE:Stop Raising Dilutive Funds
Good presentation today. Also, good to hear that Burry bought almost 800K shares recently. Ibrexa will be a billion+ dollar drug within a few short years; it'll be quite a lucrative franchise as
...more
(31)
•••
dmacd
X
Comment by
dmacd
on Nov 19, 2021 4:48pm
RE:RE:RE:Stop Raising Dilutive Funds
Good volume. Back to breakeven. The payoff has taken a while but it'll be worth it. Very tight share structure.
(31)
•••
dmacd
X
Comment by
dmacd
on Nov 16, 2021 9:55am
RE:RE:RE:Stop Raising Dilutive Funds
https://www.reuters.com/business/finance/big-short-burry-exits-bearish-bets-tesla-google-2021-11-16/ From the CEO BBs
(31)
•••
dmacd
X
Comment by
dmacd
on Nov 15, 2021 11:22pm
RE:RE:Stop Raising Dilutive Funds
Good points. I have accumulated about my limit for these speculative buy mostly derisked value stocks. I plan to hold tight for 3 to 5 years and hope management will value the SP. Thanks!
(107)
•••
JonathanJSmith
X
Comment by
JonathanJSmith
on Sep 20, 2021 8:55am
RE:Stop Raising Dilutive Funds
There's no real capital raise here or dilution (only ~1.3mm shares). They filed the recent S3/prospectuses for a couple of purposes - because the original (written 3 years ago) was expiring, and
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Criminal syndicate allegedly infiltrated Barrick Gold subsidiary
Nickel Miner Announces a Battery Supply Chain MOU with “PPES”, a JV Between Toyota and Panasonic